Comparison of single high-dose streptozotocin with partial pancreatectomy combined with low-dose streptozotocin for diabetes induction in rhesus monkeys
- PMID: 20558842
- DOI: 10.1258/ebm.2010.009361
Comparison of single high-dose streptozotocin with partial pancreatectomy combined with low-dose streptozotocin for diabetes induction in rhesus monkeys
Abstract
Monkeys with insulin-dependent diabetes are important experimental models for islet xenotransplantation. However, with regard to diabetes induction, total pancreatectomy is a difficult operation with a high complication rate, while streptozotocin (STZ) administration may cause serious toxic effects and individual difference in metabolism. We compared two strategies involving pancreatectomy and STZ to successfully and safely induce diabetes in rhesus monkeys. Thirteen rhesus monkeys were divided into two groups: single high-dose STZ administration (80, 100 and 120 mg/kg, n = 3 for each dose) (group 1) and partial pancreatectomy (70-75%) combined with low-dose STZ (15 mg/kg, n = 4) (group 2). Induction of diabetes was evaluated by blood glucose, insulin, C-peptide, intravenous glucose tolerance test (IVGTT) and arginine stimulation test (AST). Detection of hematological and serum biochemical parameters and biopsies of pancreas, liver and kidney were periodically performed. In our study, animals in both groups developed diabetes. Serum C-peptide levels in groups 1 and 2 decreased to 0.08 +/- 0.07 and 0.35 +/- 0.06 nmol/L, respectively. IVGTT and AST indicated severely impaired glucose tolerance. Immunohistochemistry demonstrated that rare insulin-positive cells remained in the pancreas. In terms of STZ toxicity, four monkeys died 8-14 days after STZ administration (3 with 120 mg/kg STZ and 1 with 100 mg/kg STZ). Group 1 animals developed liver and kidney injury evidenced by increased alanine aminotransferase, aspartate aminotransferase, total cholesterol, LDL, triglyceride and blood urea nitrogen for one month, and histological abnormality including hepatic steatosis, renal glomerulus and tubular injury. Nevertheless, moderate histological injuries were seen in animals with 80 mg/kg STZ, with subsequent recovery. In contrast, group 2 animals displayed normal biochemical parameters and histology, with generally less risk of postoperative complications. We conclude that injection of 80 mg/kg STZ could induce diabetes with moderate injuries. Partial pancreatectomy with low-dose STZ is a safer and more reproducible method for inducing diabetes in rhesus monkeys.
Similar articles
-
Induction of diabetes in rhesus monkeys and establishment of insulin administration strategy.Transplant Proc. 2009 Jan-Feb;41(1):413-7. doi: 10.1016/j.transproceed.2008.08.144. Transplant Proc. 2009. PMID: 19249568
-
Safe induction of diabetes by high-dose streptozotocin in pigs.Pancreas. 2008 Jan;36(1):31-8. doi: 10.1097/mpa.0b013e3181452886. Pancreas. 2008. PMID: 18192878
-
Induction of diabetes in cynomolgus monkeys with high-dose streptozotocin: adverse effects and early responses.Pancreas. 2006 Oct;33(3):287-92. doi: 10.1097/01.mpa.0000235307.04110.a2. Pancreas. 2006. PMID: 17003651
-
Challenges and issues with streptozotocin-induced diabetes - A clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics.Chem Biol Interact. 2016 Jan 25;244:49-63. doi: 10.1016/j.cbi.2015.11.032. Epub 2015 Dec 2. Chem Biol Interact. 2016. PMID: 26656244 Review.
-
Animal models of diabetes mellitus for islet transplantation.Exp Diabetes Res. 2012;2012:256707. doi: 10.1155/2012/256707. Epub 2012 Dec 30. Exp Diabetes Res. 2012. PMID: 23346100 Free PMC article. Review.
Cited by
-
Exacerbation of glycoprotein VI-dependent platelet responses in a rhesus monkey model of Type 1 diabetes.J Diabetes Res. 2013;2013:370212. doi: 10.1155/2013/370212. Epub 2013 Jun 6. J Diabetes Res. 2013. PMID: 23841102 Free PMC article.
-
Assessment of early renal damage in diabetic rhesus monkeys.Endocrine. 2014 Dec;47(3):783-92. doi: 10.1007/s12020-014-0211-4. Epub 2014 Mar 12. Endocrine. 2014. PMID: 24619287
-
MLKL-mediated necroptosis is a target for cardiac protection in mouse models of type-1 diabetes.Cardiovasc Diabetol. 2022 Aug 27;21(1):165. doi: 10.1186/s12933-022-01602-9. Cardiovasc Diabetol. 2022. PMID: 36030201 Free PMC article.
-
Experimental primates and non-human primate (NHP) models of human diseases in China: current status and progress.Dongwuxue Yanjiu. 2014 Nov 18;35(6):447-64. doi: 10.13918/j.issn.2095-8137.2014.6.447. Dongwuxue Yanjiu. 2014. PMID: 25465081 Free PMC article. Review.
-
Research('s) Sweet Hearts: Experimental Biomedical Models of Diabetic Cardiomyopathy.Front Cardiovasc Med. 2021 Jul 23;8:703355. doi: 10.3389/fcvm.2021.703355. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34368257 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources